Clinical Trials Browser

Phase 3 × Communicable Diseases × Sarcoma × Clear all

NCT04842071 2024-02-07

18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment

Phase 3 Unknown

Bone Diseases, Bone Neoplasms, Communicable Diseases, Joint Diseases